Akcea Therapeutics, Inc. Financing Cash Flow
Akcea Therapeutics, Inc. reported Financing Cash Flow of $3.57 million for the 6-month period ending 2020-06-30, per its 10-Q filed 2020-08-05.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2020-08-05
- Akcea Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2020-06-30 was $1.70M, a 39.60% decline year-over-year.
- Akcea Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2020-03-31 was $1.87M.
- Akcea Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2019-12-31 was $2.39M, a 30.26% increase year-over-year.
- Akcea Therapeutics, Inc. net cash provided by (used in) financing activities for the quarter ending 2019-09-30 was -$8.24M, a 684.33% decline year-over-year.
- Akcea Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2019 was -$11.93M, a 107.33% decline from fiscal 2018.
- Akcea Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2018 was $162.83M, a 43.74% decline from fiscal 2017.
- Akcea Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2017 was $289.40M.
- Akcea Therapeutics, Inc. net cash provided by (used in) financing activities for fiscal 2016 was -$818.00K.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2020-06-30 | $1.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $3.57M 10-Q · filed 2020-08-05 | $5.96M derived: sum of 3 quarters · filed 2020-08-05 | -$2.28M derived: sum of 4 quarters · filed 2020-08-05 |
| 2020-03-31 | $1.87M 10-Q · filed 2020-05-06 | $4.26M derived: sum of 2 quarters · filed 2020-05-06 | -$3.98M derived: sum of 3 quarters · filed 2020-05-06 | -$1.16M derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-12-31 | $2.39M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$5.85M derived: sum of 2 quarters · filed 2020-03-02 | -$3.03M derived: sum of 3 quarters · filed 2020-08-05 | -$11.93M 10-K · filed 2020-03-02 |
| 2019-09-30 | -$8.24M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | -$5.42M derived: sum of 2 quarters · filed 2020-08-05 | -$14.32M 10-Q · filed 2019-11-06 | -$12.49M derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-06-30 | $2.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | -$6.08M 10-Q · filed 2020-08-05 | -$4.25M derived: sum of 3 quarters · filed 2020-08-05 | -$2.84M derived: sum of 4 quarters · filed 2020-08-05 |
| 2019-03-31 | -$8.90M 10-Q · filed 2020-05-06 | -$7.07M derived: sum of 2 quarters · filed 2020-05-06 | -$5.66M derived: sum of 3 quarters · filed 2020-05-06 | $152.20M derived: sum of 4 quarters · filed 2020-05-06 |
| 2018-12-31 | $1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $3.24M derived: sum of 2 quarters · filed 2020-03-02 | $161.11M derived: sum of 3 quarters · filed 2020-03-02 | $162.83M 10-K · filed 2020-03-02 |
| 2018-09-30 | $1.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $159.27M derived: sum of 2 quarters · filed 2019-11-06 | $161.00M 10-Q · filed 2019-11-06 | $160.02M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | $157.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $159.59M 10-Q · filed 2019-08-07 | $158.61M derived: sum of 3 quarters · filed 2020-03-02 | $344.02M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | $1.72M 10-Q · filed 2019-05-09 | $744.00K derived: sum of 2 quarters · filed 2020-03-02 | $186.16M derived: sum of 3 quarters · filed 2020-03-02 | $200.58M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | -$980.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $184.43M derived: sum of 2 quarters · filed 2020-03-02 | $198.86M derived: sum of 3 quarters · filed 2020-03-02 | $289.40M 10-K · filed 2020-03-02 |
| 2017-09-30 | $185.41M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $199.84M derived: sum of 2 quarters · filed 2018-11-06 | $290.38M 10-Q · filed 2018-11-06 | $290.44M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $14.43M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $104.97M 10-Q · filed 2018-08-07 | $105.03M derived: sum of 3 quarters · filed 2019-03-01 | $104.63M derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $90.54M 10-Q · filed 2018-05-07 | $90.60M derived: sum of 2 quarters · filed 2019-03-01 | $90.21M derived: sum of 3 quarters · filed 2019-03-01 | |
| 2016-12-31 | $62.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$335.00K derived: sum of 2 quarters · filed 2019-03-01 | -$818.00K 10-K · filed 2019-03-01 | |
| 2016-09-30 | -$397.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | -$880.00K 10-Q · filed 2017-11-07 | ||
| 2016-06-30 | -$483.00K 10-Q · filed 2017-08-09 | |||
| 2015-12-31 | $108.69M 8-K · filed 2018-09-18 |